The study “The Role of Europe in the Global Cardiovascular Diseases Network” aims to provide evidenced-based input on the current debates around European life science and EU policy making. How could European life science industries be strengthened? How could Europe deepen the embeddedness of life science research and industries within the globalized flow of knowledge, clinical trials and investment capital? The essential role of established European life science and pharma industry as well as questions around Chinese-European partnerships in life sciences are of special interest.
You can find the study here: